Taurus Allen
Family Medicine · Spartanburg, SCNPI 1699126888
Payments from drug & device makers
Across 140 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$776
- Novo Nordisk$491
- Otsuka America Pharmaceutical, Inc.$205
- GSK$186
- Merck$165
- Dexcom, Inc.$134
- plus $597 from 17 others
What the payments were for
- Food & beverage$2,554100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $776 |
| Novo Nordisk | 29 | $491 |
| Otsuka America Pharmaceutical, Inc. | 8 | $205 |
| GSK | 10 | $186 |
| Merck | 10 | $165 |
| Dexcom, Inc. | 9 | $134 |
| Mylan Specialty L.p. | 7 | $120 |
| Pfizer | 4 | $74 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $65 |
| Lilly USA, LLC | 3 | $49 |
| Amgen | 2 | $35 |
| AstraZeneca | 2 | $32 |
| Bayer | 2 | $29 |
| Abbott | 1 | $26 |
| Boehringer Ingelheim | 2 | $26 |
| Davol Inc. | 1 | $23 |
| Exact Sciences | 1 | $22 |
| Edwards Lifesciences | 1 | $21 |
| Genentech USA, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Innocoll Pharmaceuticals Limited | 1 | $14 |
| Tris Pharma Inc | 1 | $12 |
How this compares
$2,554 in reported general payments places this provider in the 75th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 82 | $87,382 |
| OzempicSemaglutide | 65 | $62,239 |
| JardianceEmpagliflozin | 65 | $47,922 |
| TrulicityDulaglutide | 42 | $43,983 |
| EliquisApixaban | 53 | $37,603 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $17,771 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $16,218 |
| LinzessLinaclotide | 18 | $9,951 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 18 | $7,911 |
| VascepaIcosapent Ethyl | 11 | $5,766 |
| Incruse ElliptaUmeclidinium Bromide | 16 | $5,570 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $5,239 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $4,019 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 95 | $3,060 |
| Atorvastatin Calcium | 353 | $3,019 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $49 | $131,365124 claims |
| Novo NordiskOzempic | $491 | $62,23965 claims |
| Boehringer IngelheimJardiance | $26 | $47,92265 claims |
| PfizerEliquis | $74 | $37,60353 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $186 | $23,34142 claims |
| AbbVieLinzess | $776 | $9,95118 claims |
| MerckJanumet Xr | $165 | $7,91118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Spartanburg
- Latasha SelibySpartanburg$24K
- George BailesSpartanburg$22K
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.